Diestro Jose Danilo Bengzon, Li Yangmei, Kishore Kislay, Omar Abdelsimar T, Montanera Walter, Sarma Dipanka, Marotta Thomas R, Spears Julian, Bharatha Aditya
Department of Medical Imaging, Division of Diagnostic and Therapeutic Neuroradiology, St Michael's Hospital, University of Toronto, Toronto, Canada.
Department of Surgery, Division of Neurosurgery, Department of Surgery, St. Michael's Hospital, University of Toronto, Toronto, Canada.
Neuroradiology. 2023 Sep;65(9):1353-1361. doi: 10.1007/s00234-023-03195-w. Epub 2023 Jul 22.
Middle cerebral aneurysms were underrepresented in the two largest trials (BRAT and ISAT) for the treatment of ruptured intracranial aneurysms. Recent institutional series addressing the choice between endovascular or open repair for this subset of aneurysms are few and have not yielded a definitive conclusion. We compare clinical outcomes of patients presenting with acute subarachnoid hemorrhage from ruptured middle cerebral artery aneurysms undergoing either open or endovascular repair.
We conducted a retrospective review of 138 consecutive patients with ruptured middle cerebral artery aneurysms admitted into our institution from January 2008 to March 2019 to compare endovascular and open surgical outcomes.
Of the ruptured middle cerebral artery aneurysms, 57 underwent endovascular repair while 81 were treated with open surgery. Over the study period, there was a notable shift in practice toward more frequent endovascular treatment of ruptured MCA aneurysms (31% in 2008 vs. 91% in 2018). At discharge (49.1% vs 29.6%; p = .002) and at 6 months (84.3% vs 58.6%; p = 0.003), patients who underwent endovascular repair had a higher proportion of patients with good clinical outcomes (mRS 0-2) compared to those undergoing open surgery. Long-term follow-up data (endovascular 54.9 ± 37.9 months vs clipping 18.6 ± 13.4 months) showed no difference in rebleeding (1.8% vs 3.7%, p = 0.642) and retreatment (5.3% vs 3.7%, p = 0.691) in both groups.
Our series suggests equipoise in the treatment of ruptured middle cerebral artery aneurysms and demonstrates endovascular repair as a potentially feasible treatment strategy. Future randomized trials could clarify the roles of these treatment modalities.
在两项最大规模的颅内破裂动脉瘤治疗试验(BRAT和ISAT)中,大脑中动脉瘤的占比不足。近期针对该类动脉瘤血管内修复或开放修复选择的机构性系列研究较少,且尚未得出明确结论。我们比较了因大脑中动脉动脉瘤破裂导致急性蛛网膜下腔出血的患者接受开放修复或血管内修复后的临床结局。
我们对2008年1月至2019年3月期间连续收治入我院的138例大脑中动脉动脉瘤破裂患者进行了回顾性研究,以比较血管内修复和开放手术的结局。
在大脑中动脉动脉瘤破裂患者中,57例行血管内修复,81例行开放手术治疗。在研究期间,对于破裂的大脑中动脉动脉瘤,治疗方式明显转向更频繁地采用血管内治疗(2008年为31%,2018年为91%)。在出院时(49.1%对29.6%;p = 0.002)和6个月时(84.3%对58.6%;p = 0.003),与接受开放手术的患者相比,接受血管内修复的患者临床结局良好(改良Rankin量表评分0 - 2分)的比例更高。长期随访数据(血管内修复组54.9±37.9个月,夹闭组18.6±13.4个月)显示,两组再出血(1.8%对3.7%,p = 0.642)和再次治疗(5.3%对3.7%,p = 0.691)情况无差异。
我们的系列研究表明,在大脑中动脉动脉瘤破裂的治疗上两种方法效果相当,并证明血管内修复是一种潜在可行的治疗策略。未来的随机试验可能会明确这些治疗方式的作用。